LZTR1 and autoimmune disease: Our study provides critical information on this and identifies LZTR1 as a major component in activating CD8+ TRM within both the skin and gastrointestinal epithelium to amplify inflammation in an MHC-I-dependent manner, providing a sharp departure from the conventional pathogenic loop between DC and CD4+ T in autoimmune diseases such as psoriasis13.